NFKB1 and chronic obstructive pulmonary disease: After a 12-week intervention, crocin reduced the total oxidant status and nuclear factor kappa B (NF-κB) serum levels and increased the total antioxidant capacity and exercise capacity (6MWD) of COPD patients [51].